The effects of pharmacological manipulation of the lower esophageal sphincter pressure on the esophageal circulation in patients with cirrhosis and portal hypertension were investigated in 33 patients by measuring the azygos venous blood flow, which is an index of blood flow through esophageal varic
Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis
β Scribed by Jaime Bosch; Ricardo Masti; David Kravetz; Jordi Bruix; Joan Gaya; Joaquin Rigau; Joan Rodes
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 680 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
The effects of propranolol on blood flow through gastroesophageal collaterals and on systemic and hepatic hemodynamics were investigated in 23 cirrhotic patients with portal hypertension. Gastroesophageal collateral blood flow was evaluated by the measurement of azygos venous blood flow by continuous thermal dilution. Azygos venous blood flow was markedly increased in these patients (544 f 48 ml per min, as compared with 132 f 18 ml per min in subjects without portal hypertension (p c 0.001).
Propranolol at doses achieving effective @-blockage (83 f 5 mg) (mean f S.E.M.) markedly reduced azygos venous blood flow (to 354 f 34 ml per min, p < 0.001). Reduction of azygos venous blood flow (-34.2 f 3.6%) was significantly greater (p < 0.01) than reductions in cardiac output (-22.6 f 1.9%), hepatic venous pressure gradient (-11.5 f 2.4%) and hepatic blood flow (-13.4 f 7.4%). The hemodynamic effects of propranolol were not related to plasma norepinephrine levels.
Reduction of gastroesophageal collateral blood flow may be the mechanism by which oral propranolol therapy reduces the risk of repeated episodes of variceal bleeding in cirrhotic patients with portal hypertension.
π SIMILAR VOLUMES
Circulating catecholamines are increased in cirrhosis with portal hypertension, and increase further after propranolol. In 23 cirrhotic patients, plasma norepinephrine and epinephrine were determined in an artery, the azygos vein, the right renal vein and a hepatic vein before and after an oral 80-m
This study investigated the correlation between changes in hepatic hemodynamics and esophageal variceal pressuremeasured with a noninvasive, pressure-sensitive endoscopic gaugein 37 portal-hypertensive cirrhotic patients receiving propranolol (0.15 mg/kg, intravenously; n = 21) or placebo (n = 16) u
no further renal vasodilatation except at very high phar-Insulin has been shown to be vasodilatory and antinamacological levels of insulin together with an untriuretic and to stimulate sympathetic nervous activity changed GFR, natriuresis, and diuresis. Hyperinsulinindependent of hypoglycemia in hea
The effects of verapamil on hepatic and systemic hemodynamics and on liver function were investigated in 10 patients with portal hypertension due to advanced micronodular cirrhosis to verify whether, as it has been suggested, this calcium channel blocker may improve liver function and reduce portal
Propranolol has been reported to reduce portal and wedged hepatic vein pressures in man and may be useful for the prevention of variceal bleeding. However, its mechanism of action remains unclear. We have examined the effect of propranolol on the systemic and hepatic circulations in dogs with chroni